Skip to main content
. 2014 Oct 18;14(6):451–462. doi: 10.1007/s40256-014-0092-1

Fig. 3.

Fig. 3

Scatter plots reflecting the uncertainty in the differences in costs and effectiveness between the new oral anticoagulants and coumarins (based on probabilistic sensitivity analysis). QALY quality-adjusted life-year